Literature DB >> 696462

Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.

K S Price, I J Farley, O Hornykiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 696462

Source DB:  PubMed          Journal:  Adv Biochem Psychopharmacol        ISSN： 0065-2229


× No keyword cloud information.
  15 in total

1.  Dopamine receptors mediate strategy abandoning via modulation of a specific prelimbic cortex-nucleus accumbens pathway in mice.

Authors:  Qiaoling Cui; Qian Li; Hongyan Geng; Lei Chen; Nancy Y Ip; Ya Ke; Wing-Ho Yung
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 2.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

3.  Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

Authors:  R G Brown; C D Marsden; N Quinn; M A Wyke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

4.  The effect of Parkinson's disease on the ability to maintain a mental set.

Authors:  K A Flowers; C Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

5.  Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.

Authors:  J Balldin; S Edén; A K Granérus; K Modigh; A Svanborg; J Wålinder; L Wallin
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 6.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

Review 7.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

8.  Relatively high levels of dopamine in nucleus accumbens of levodopa treated patients with Parkinson's disease.

Authors:  M Goldstein; A Lieberman; J Pearson
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

9.  Cognitive concomitants of dopamine system stimulation in parkinsonian patients.

Authors:  E Mohr; G Fabbrini; S Ruggieri; P Fedio; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

Review 10.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.